Actinium Pharmaceuticals, Inc.
ATNM
$1.45
$0.000.00%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -41.54% | -70.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -22.94% | -54.90% | |||
| Operating Income | 24.14% | 54.90% | |||
| Income Before Tax | 25.40% | 56.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.40% | 56.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.40% | 56.85% | |||
| EBIT | 24.14% | 54.90% | |||
| EBITDA | 24.84% | 55.58% | |||
| EPS Basic | 25.40% | 56.84% | |||
| Normalized Basic EPS | 25.40% | 56.84% | |||
| EPS Diluted | 25.40% | 56.84% | |||
| Normalized Diluted EPS | 25.40% | 56.84% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||